InMed Pharmaceuticals (INM) Assets (2021 - 2025)
Historic Assets for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $11.2 million.
- InMed Pharmaceuticals' Assets rose 3162.9% to $11.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.2 million, marking a year-over-year increase of 3162.9%. This contributed to the annual value of $15.6 million for FY2025, which is 3177.98% up from last year.
- Latest data reveals that InMed Pharmaceuticals reported Assets of $11.2 million as of Q4 2025, which was up 3162.9% from $13.4 million recorded in Q3 2025.
- In the past 5 years, InMed Pharmaceuticals' Assets registered a high of $19.4 million during Q4 2021, and its lowest value of $8.5 million during Q4 2024.
- Moreover, its 5-year median value for Assets was $13.7 million (2023), whereas its average is $13.6 million.
- Its Assets has fluctuated over the past 5 years, first tumbled by 4426.72% in 2024, then surged by 3177.98% in 2025.
- Quarter analysis of 5 years shows InMed Pharmaceuticals' Assets stood at $19.4 million in 2021, then decreased by 12.71% to $16.9 million in 2022, then decreased by 9.84% to $15.3 million in 2023, then plummeted by 44.27% to $8.5 million in 2024, then soared by 31.63% to $11.2 million in 2025.
- Its last three reported values are $11.2 million in Q4 2025, $13.4 million for Q3 2025, and $15.6 million during Q2 2025.